Industry Reports
The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >
The 2025-26 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >
From The Drug Channels Blog
Friday, June 5, 2026
Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight
Today’s guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS Rx’s proprietary data and case studies, Stephen highlights patterns more >
Tuesday, June 2, 2026
The 340B Contract Pharmacy Market in 2026: A Maturing Industry Dominated by Big Chains and PBMs
By Adam J. Fein, Ph.D. and Greis Kapexhiu It’s time for Drug Channels Institute’s latest exclusive analysis of the 340B contract pharmacy market, which continues to boom along with the more >
